Epigenetic advances in clinical neuroscience
Language: 
English
Abstract: 

Epigenetics, broadly defined as the regulation of gene expression without alteration of the genome, has become a field of tremendous interest in neuroscience, neurology, and psychiatry. This research has rapidly changed the way researchers think about brain function. Exciting epigenetic discoveries have been found in addiction, early life stress, neurodegeneration, post-traumatic stress disorder, and depression. As researchers more precisely define the epigenetic landscape that regulates disease progression in each of these cases, therapeutics can be designed to specifically target the molecules that mediate these epigenetic processes. Further, epigenetics may lead, to the identification of novel biomarkers for diagnosis and for the monitoring of treatment. Epigenetic profiling is likely to become a routine tool for the diagnosis of neurological and psychiatric disorders in the near future.

Author(s): 
Abel, Ted
Poplawski, Shane
Item Type: 
Journal Article
Publication Title: 
Dialogues in Clinical Neuroscience
Journal Abbreviation: 
Dialogues Clin Neurosci
Publication Date: 
2014-09
Publication Year: 
2014
Pages: 
273-275
Volume: 
16
Issue: 
3
ISSN: 
1958-5969
Library Catalog: 
PubMed
Extra: 
PMID: 25364279 PMCID: PMC4214171

Turabian/Chicago Citation

Ted Abel and Shane Poplawski. 2014-09. "Epigenetic advances in clinical neuroscience." Dialogues in Clinical Neuroscience 16: 3: 273-275.

Wikipedia Citation

<ref> {{Cite journal | doi = | issn = 1958-5969 | volume = 16 | pages = 273-275 | last = Abel | first = Ted | coauthors = Poplawski, Shane | title = Epigenetic advances in clinical neuroscience | journal = Dialogues in Clinical Neuroscience | date = 2014-09 | pmid = | pmc = }} </ref>